Pharmacokinetic Profiles of High-Dose Intravenous Ciprofloxacin in Severe Sepsis
The pharmacokinetics of 400 mg of ciprofloxacin given intravenously (i.v.) every 8 h (q8h) in severely septic adults was documented in a multidisciplinary, tertiary referral intensive care unit (ICU). Sixteen evaluable patients (three pharmacokinetic profiles) without renal dysfunction and with seve...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1998
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105792/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9736541/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.9.2235 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
